We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$2.54B
Cap. Flow
+$1.55B
Cap. Flow %
7.41%
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$798M
2
XOM icon
ExxonMobil
XOM
+$189M
3
CTSH icon
Cognizant
CTSH
+$86.4M
4
MRK icon
Merck
MRK
+$80.6M
5
IART icon
Integra LifeSciences
IART
+$47.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$57.5M
2
PEP icon
PepsiCo
PEP
+$55.1M
3
DG icon
Dollar General
DG
+$49.7M
4
WOOF
VCA Inc.
WOOF
+$48.1M
5
SPG icon
Simon Property Group
SPG
+$45.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.52%
2 Technology 14.11%
3 Financials 12.07%
4 Industrials 10.58%
5 Consumer Discretionary 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPTN
2126
DELISTED
NEOPHOTONICS CORP
NPTN
$2K ﹤0.01%
283
-1,378,330
-100% -$14.4M
AT
2127
DELISTED
Atlantic Power Corporation
AT
$2K ﹤0.01%
+830
New +$2.04K
MIK
2128
DELISTED
Michaels Stores, Inc
MIK
$2K ﹤0.01%
+97
New +$2.04K
ACIA
2129
DELISTED
Acacia Communications Inc
ACIA
$2K ﹤0.01%
35
-427
-92% -$24.8K
FIT
2130
DELISTED
Fitbit, Inc. Class A common stock
FIT
$2K ﹤0.01%
379
OPB
2131
DELISTED
Opus Bank Common Stock
OPB
$2K ﹤0.01%
+104
New +$2.38K
AKRX
2132
DELISTED
Akorn Inc
AKRX
$2K ﹤0.01%
146
+70
+92% +$1.52K
AVP
2133
DELISTED
Avon Products, Inc.
AVP
$2K ﹤0.01%
651
CRR
2134
DELISTED
Carbo Ceramics Inc.
CRR
$2K ﹤0.01%
+219
New +$2.8K
DEST
2135
DELISTED
Destination Maternity Corporation
DEST
$2K ﹤0.01%
580
PCMI
2136
DELISTED
PCM, Inc
PCMI
$2K ﹤0.01%
+100
New +$2.55K
BKS
2137
DELISTED
Barnes & Noble
BKS
$2K ﹤0.01%
+280
New +$2.8K
ACET
2138
DELISTED
Aceto Corp
ACET
$2K ﹤0.01%
+164
New +$2.8K
SVU
2139
DELISTED
SUPERVALU Inc.
SVU
$2K ﹤0.01%
+101
New +$2.76K
PAY
2140
DELISTED
Verifone Systems Inc
PAY
$2K ﹤0.01%
+125
New +$2.38K
KND
2141
DELISTED
Kindred Healthcare
KND
$2K ﹤0.01%
348
+248
+248% +$1.94K
IPXL
2142
DELISTED
Impax Laboratories, Inc.
IPXL
$2K ﹤0.01%
196
+157
+403% +$1.9K
SCMP
2143
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$2K ﹤0.01%
225
BSFT
2144
DELISTED
BroadSoft, Inc.
BSFT
$2K ﹤0.01%
+55
New +$2.34K
ATW
2145
DELISTED
Atwood Oceanics
ATW
$2K ﹤0.01%
300
+214
+249% +$2.39K
AMRI
2146
DELISTED
Albany Molecular Research Inc
AMRI
$2K ﹤0.01%
163
+146
+859% +$2.39K
MEET
2147
DELISTED
The Meet Group, Inc. Common Stock
MEET
$2K ﹤0.01%
+500
New +$2.54K
TDK
2148
DELISTED
TDK CORP AMER DEP SH
TDK
$2K ﹤0.01%
45
+18
+67% +$800
DQU.PRD
2149
DELISTED
DUQUESNE LT 4.10% PFD
DQU.PRD
$2K ﹤0.01%
50
VVUS
2150
DELISTED
Vivus Inc
VVUS
$2K ﹤0.01%
250

Similar funds

Glenmede Trust's Q1 2017 Portfolio in Review

As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.

  • Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
  • Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
  • Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
  • Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
  • Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
  • Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
  • Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.